Anavex生命科學 AVXL
-
-
-
•
開盤中：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 10.74 | 112.23 | -0.14 | -13,592 | -12 | |
| 2024Q3 | 5.68 | 122.07 | -0.14 | -14,336 | -12 | |
| 2024Q2 | 4.22 | 119.93 | -0.15 | -14,729 | -12 | |
| 2024Q1 | 5.09 | 120.08 | -0.12 | -12,434 | -11 | |
| 2023Q4 | 9.31 | 132.28 | -0.11 | -11,293 | -9 | |
| 2023Q3 | 6.55 | 123.92 | -0.13 | -12,652 | -10 | |
| 2023Q2 | 8.13 | 120.39 | -0.14 | -13,531 | -11 | |
| 2023Q1 | 8.57 | 108.67 | -0.16 | -14,189 | -13 | |
| 2022Q4 | 9.26 | 118.41 | -0.17 | -15,384 | -13 | |
| 2022Q3 | 10.32 | 108.55 | -0.18 | -15,284 | -14 | |
| 2022Q2 | 10.01 | 101.47 | -0.16 | -12,459 | -12 | |
| 2022Q1 | 12.31 | 110.68 | -0.14 | -11,520 | -10 | |
| 2021Q4 | 17.34 | 107.98 | -0.14 | -11,723 | -11 | |
| 2021Q3 | 17.95 | 105.84 | -0.15 | -12,252 | -12 | |
| 2021Q2 | 22.86 | 112.41 | -0.15 | -11,399 | -10 | |
| 2021Q1 | 14.95 | 110.15 | -0.12 | -8,955 | -8 | |
| 2020Q4 | 5.40 | 120.55 | -0.12 | -9,396 | -8 | |
| 2020Q3 | 4.55 | 126.04 | -0.10 | -7,508 | -6 | |
| 2020Q2 | 4.92 | 125.07 | -0.11 | -8,106 | -6 | |
| 2020Q1 | 3.15 | 108.11 | -0.12 | -7,773 | -7 |
